Literature DB >> 17567660

Hypoxia-inducible factor expression in human RPE cells.

Farzin Forooghian1, Rozita Razavi, Lee Timms.   

Abstract

BACKGROUND: Hypoxia-inducible factor (HIF) is a common transcription factor for many angiogenic proteins. Retinal pigment epithelial (RPE) cells are an important source of angiogenic factors in the retina. The expression of HIF, its regulation by proline hydroxylase (PHD) enzymes, and its downstream regulation of angiogenic factors like vascular endothelial growth factor (VEGF) and erythropoietin (EPO) was studied in RPE cells in order to determine some of the molecular mechanisms underlying ischaemic retinal disease.
METHODS: ARPE-19 cells were cultured for various times under hypoxic conditions. Cellular HIF and PHD isoforms were analysed and quantified using western blot and densitometry. VEGF and EPO secreted into the media were assayed using enzyme-linked immunosorbent assay (ELISA). Messenger RNA (mRNA) was quantified using real-time quantitative reverse transcriptase polymerase chain reaction (qPCR). RNA interference was achieved using siRNA techniques.
RESULTS: HIF-1 alpha was readily produced by ARPE-19 cells under hypoxia, but HIF-2 alpha and HIF-3 alpha could not be detected even after HIF-1 alpha silencing. HIF-1 alpha protein levels showed an increasing trend for the first 24 h while HIF-1 alpha mRNA levels fluctuated during this time. After 36 h HIF-1 alpha protein levels declined to baseline levels, a change that was coincident with a rise in both PHD2 and PHD3. Silencing HIF-1 alpha significantly decreased VEGF secretion. Significant production of EPO could not be detected at the protein or mRNA level.
CONCLUSIONS: HIF-1 alpha appears to be the main isoform of HIF functioning in ARPE-19 cells. Under hypoxia, HIF-1 alpha levels are likely self-regulated by a feedback loop that involves both transcriptional and post-translational mechanisms. VEGF production by human RPE cells is regulated by HIF-1 alpha. EPO was not produced in significant amounts by RPE cells under hypoxic conditions, suggesting that other cells and/or transcription factors in the retina are responsible for its production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567660      PMCID: PMC2001032          DOI: 10.1136/bjo.2007.123125

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  34 in total

1.  Signal transduction. How do cells sense oxygen?

Authors:  H Zhu; H F Bunn
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

Review 2.  The HIF pathway as a therapeutic target.

Authors:  Kirsty S Hewitson; Christopher J Schofield
Journal:  Drug Discov Today       Date:  2004-08-15       Impact factor: 7.851

Review 3.  The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses.

Authors:  C P Bracken; M L Whitelaw; D J Peet
Journal:  Cell Mol Life Sci       Date:  2003-07       Impact factor: 9.261

4.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

Review 5.  Vascular endothelial growth factors and angiogenesis in eye disease.

Authors:  A N Witmer; G F J M Vrensen; C J F Van Noorden; R O Schlingemann
Journal:  Prog Retin Eye Res       Date:  2003-01       Impact factor: 21.198

Review 6.  Regulation of transcription and translation by hypoxia.

Authors:  Liping Liu; M Celeste Simon
Journal:  Cancer Biol Ther       Date:  2004-06-08       Impact factor: 4.742

7.  Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs.

Authors:  Michael S Wiesener; Jan Steffen Jürgensen; Christian Rosenberger; Charlotte K Scholze; Jan H Hörstrup; Christina Warnecke; Stefano Mandriota; Ingo Bechmann; Ulrich A Frei; Christopher W Pugh; Peter J Ratcliffe; Sebastian Bachmann; Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  FASEB J       Date:  2002-12-17       Impact factor: 5.191

Review 8.  Molecular biology of erythropoietin.

Authors:  Wolfgang Jelkmann
Journal:  Intern Med       Date:  2004-08       Impact factor: 1.271

9.  HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration.

Authors:  Christian Grimm; Andreas Wenzel; Matthias Groszer; Helmut Mayser; Mathias Seeliger; Marijana Samardzija; Christian Bauer; Max Gassmann; Charlotte E Remé
Journal:  Nat Med       Date:  2002-06-17       Impact factor: 53.440

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  30 in total

Review 1.  Iron metabolism in the eye: a review.

Authors:  M Goralska; J Ferrell; J Harned; M Lall; S Nagar; L N Fleisher; M C McGahan
Journal:  Exp Eye Res       Date:  2008-11-21       Impact factor: 3.467

2.  Concerted inhibition of HIF-1α and -2α expression markedly suppresses angiogenesis in cultured RPE cells.

Authors:  Takeshi Nakajima; Emi Nakajima; Thomas R Shearer; Mitsuyoshi Azuma
Journal:  Mol Cell Biochem       Date:  2013-07-20       Impact factor: 3.396

3.  Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro.

Authors:  R K Vadlapatla; A D Vadlapudi; D Pal; M Mukherji; A K Mitra
Journal:  Eye (Lond)       Date:  2013-11-08       Impact factor: 3.775

Review 4.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Authors:  Chung-Jung Chiu; Allen Taylor
Journal:  Prog Retin Eye Res       Date:  2010-09-22       Impact factor: 21.198

5.  Aqueous humor and serum erythropoietin levels in patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma.

Authors:  Başak Doğu; Nurşen Yüksel; Mustafa Baki Cekmen; Yusuf Cağlar
Journal:  Int Ophthalmol       Date:  2010-09-23       Impact factor: 2.031

6.  Hypoxia-inducible factor and vascular endothelial growth factor in the neuroretina and retinal blood vessels after retinal ischemia.

Authors:  Gisela Håkansson; Bodil Gesslein; Lotta Gustafsson; Ulrica Englund-Johansson; Malin Malmsjö
Journal:  J Ocul Biol Dis Infor       Date:  2010-05-27

7.  Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.

Authors:  Hu Huang; Sara Van de Veire; Mansi Dalal; Rachel Parlier; Richard D Semba; Peter Carmeliet; Stanley A Vinores
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

8.  Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells.

Authors:  Xuebin Liu; Marie G Mameza; Yun Sang Lee; Chikezie I Eseonu; Cheng-Rong Yu; Jennifer J Kang Derwent; Charles E Egwuagu
Journal:  Diabetes       Date:  2008-03-20       Impact factor: 9.461

9.  Inhibition of proliferation, migration and tube formation of choroidal microvascular endothelial cells by targeting HIF-1alpha with short hairpin RNA-expressing plasmid DNA in human RPE cells in a coculture system.

Authors:  Wei Zhao; Yu-Sheng Wang; Yan-Nian Hui; Jie Zhu; Peng Zhang; Xia Li; Guo-Rui Dou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-04       Impact factor: 3.117

10.  Regulation of Na,K-ATPase β1-subunit in TGF-β2-mediated epithelial-to-mesenchymal transition in human retinal pigmented epithelial cells.

Authors:  Sridevi Mony; Seung Joon Lee; Jeffrey F Harper; Sonali P Barwe; Sigrid A Langhans
Journal:  Exp Eye Res       Date:  2013-06-28       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.